Kentucky Trust Co Makes New $751,000 Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Kentucky Trust Co bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 37,060 shares of the real estate investment trust's stock, valued at approximately $751,000.

Several other institutional investors have also added to or reduced their stakes in DOC. State Street Corp purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $1,093,576,000. Geode Capital Management LLC purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $403,898,000. Charles Schwab Investment Management Inc. purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $102,615,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on DOC shares. Mizuho cut their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Robert W. Baird cut their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Tuesday. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a "hold" rating to a "buy" rating and raised their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada raised their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $24.00.

Healthpeak Properties Trading Down 1.9 %

Shares of DOC stock traded down $0.39 on Friday, reaching $19.57. 4,495,661 shares of the company's stock were exchanged, compared to its average volume of 4,675,860. Healthpeak Properties, Inc. has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.31 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $13.69 billion, a PE ratio of 55.92, a P/E/G ratio of 2.18 and a beta of 1.15. The company's fifty day simple moving average is $20.36 and its 200 day simple moving average is $21.46.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a dividend of $0.305 per share. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.23%. The ex-dividend date is Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 342.87%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.